AllPennyStocks.com CAPR Stock Explodes Premarket: Cantor Flips Bullish, Sees 278% Upside On Deramiocel FDA Path
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

CAPR Stock Explodes Premarket: Cantor Flips Bullish, Sees 278% Upside On Deramiocel FDA Path

Cantor Fitzgerald upgraded Capricor to ‘Overweight’ from ‘Neutral’ and raised its price target to $28 from $3.50, just weeks after the firm slashed its price target to $3.50 from $62.

Other Penny Stock Movers

Casino Tables Are Going Social, and This Microcap Just Expanded Its Reach
Canadian Defense Tech Firm Jumps 92% as Government Revenue Boosts Margins
Fiji Gold Explorer Gains 30% as Field Access Clears and Strategic Backing Closes
Most Popular
{{ index + 1 }}


Back to Top